Literature DB >> 18443958

The extracellular matrix protein 1: its molecular interaction and implication in tumor progression.

S Sercu1, L Zhang, J Merregaert.   

Abstract

The extracellular matrix protein 1 (ECM1) is expressed around blood vessels, which suggest a role for ECM1 in angiogenesis. Recombinant ECM1 stimulates proliferation of cultured endothelial cells and promotes blood vessel formation in the chorioallantoic membrane of chicken embryos. These observations make ECM1 a possible trigger for angiogenesis, tumor progression and malignancies. Interaction of ECM1 with perlecan, MMP-9 and fibulin-1C/D contributes to this hypothesis. However, the importance of ECM1 in cancer biology has been neglected so far. Nevertheless, a survey of ECM1 expression in different tumors indicated that ECM1, although not tumor specific, is significantly elevated in many malignant epithelial tumors that give rise to metastases, emphasizing its relevance in the cancer process.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18443958     DOI: 10.1080/07357900701788148

Source DB:  PubMed          Journal:  Cancer Invest        ISSN: 0735-7907            Impact factor:   2.176


  35 in total

1.  Phospholipid scramblase 1 is secreted by a lipid raft-dependent pathway and interacts with the extracellular matrix protein 1 in the dermal epidermal junction zone of human skin.

Authors:  Joseph Merregaert; Johanna Van Langen; Uwe Hansen; Peter Ponsaerts; Abdoelwaheb El Ghalbzouri; Ellen Steenackers; Xaveer Van Ostade; Sandy Sercu
Journal:  J Biol Chem       Date:  2010-09-24       Impact factor: 5.157

2.  Correlation of perfusion parameters with genes related to angiogenesis regulation in glioblastoma: a feasibility study.

Authors:  R Jain; L Poisson; J Narang; L Scarpace; M L Rosenblum; S Rempel; T Mikkelsen
Journal:  AJNR Am J Neuroradiol       Date:  2012-03-15       Impact factor: 3.825

3.  An atlas of bloodstream-accessible bone marrow proteins for site-directed therapy of acute myeloid leukemia.

Authors:  L Angenendt; S Reuter; D Kentrup; A S Benk; F Neumann; J Hüve; A C Martens; C Schwöppe; T Kessler; L H Schmidt; T Sauer; C Brand; J-H Mikesch; G Lenz; R M Mesters; C Müller-Tidow; W Hartmann; E Wardelmann; D Neri; W E Berdel; C Roesli; C Schliemann
Journal:  Leukemia       Date:  2017-06-30       Impact factor: 11.528

4.  Identification of recurrent c.742G>T nonsense mutation in ECM1 in Pakistani families suffering from lipoid proteinosis.

Authors:  Muhammad Nasir; Simeen Ber Rahman; Christian M K Sieber; Asif Mir; Amir Latif; Nafees Ahmad; Salman Akbar Malik; Abdul Hameed
Journal:  Mol Biol Rep       Date:  2014-01-12       Impact factor: 2.316

5.  Extracellular matrix protein 1, a novel prognostic factor, is associated with metastatic potential of hepatocellular carcinoma.

Authors:  Hao Chen; Wei-Dong Jia; Jian-Sheng Li; Wei Wang; Ge-Liang Xu; Jin-Liang Ma; Wei-Hua Ren; Yong-Sheng Ge; Ji-Hai Yu; Wen-Bin Liu; Chuan-Hai Zhang; Yong-Cang Wang
Journal:  Med Oncol       Date:  2010-12-03       Impact factor: 3.064

6.  Extracellular matrix 1 (ECM1) regulates the actin cytoskeletal architecture of aggressive breast cancer cells in part via S100A4 and Rho-family GTPases.

Authors:  P Gómez-Contreras; J M Ramiro-Díaz; A Sierra; C Stipp; F E Domann; R J Weigel; G Lal
Journal:  Clin Exp Metastasis       Date:  2016-10-21       Impact factor: 5.150

7.  CD44v6 coordinates tumor matrix-triggered motility and apoptosis resistance.

Authors:  Thorsten Jung; Wolfgang Gross; Margot Zöller
Journal:  J Biol Chem       Date:  2011-03-03       Impact factor: 5.157

8.  Effects of VIP on corneal reconstitution and homeostasis following Pseudomonas aeruginosa induced keratitis.

Authors:  Elizabeth A Berger; Kerry S Vistisen; Ronald P Barrett; Linda D Hazlett
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-11-01       Impact factor: 4.799

9.  A Novel ECM1 Splice Site Mutation in Lipoid Proteinosis: Case Report plus Review of the Literature.

Authors:  Linda K Rey; Jürgen Kohlhase; Katrin Möllenhoff; Gabriele Dekomien; Jörg T Epplen; Sabine Hoffjan
Journal:  Mol Syndromol       Date:  2016-03-15

Review 10.  Matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) in the tumors of central nervous system (CNS).

Authors:  Marta Lukaszewicz-Zając; Barbara Mroczko; Johannes Kornhuber; Piotr Lewczuk
Journal:  J Neural Transm (Vienna)       Date:  2013-12-24       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.